127 related articles for article (PubMed ID: 8840971)
41. Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation.
Martinsson H; Yhr M; Enerbäck C
Exp Dermatol; 2005 Mar; 14(3):161-8. PubMed ID: 15740587
[TBL] [Abstract][Full Text] [Related]
42. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
[TBL] [Abstract][Full Text] [Related]
43. Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast.
Vos CB; Ter Haar NT; Peterse JL; Cornelisse CJ; van de Vijver MJ
J Pathol; 1999 Feb; 187(3):279-84. PubMed ID: 10398079
[TBL] [Abstract][Full Text] [Related]
44. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
45. The role of HER2/neu overexpression/amplification in the progression of ductal carcinoma in situ to invasive carcinoma of the breast.
Latta EK; Tjan S; Parkes RK; O'Malley FP
Mod Pathol; 2002 Dec; 15(12):1318-25. PubMed ID: 12481013
[TBL] [Abstract][Full Text] [Related]
46. Immunohistological localisation of human FAT1 (hFAT) protein in 326 breast cancers. Does this adhesion molecule have a role in pathogenesis?
Kwaepila N; Burns G; Leong AS
Pathology; 2006 Apr; 38(2):125-31. PubMed ID: 16581652
[TBL] [Abstract][Full Text] [Related]
47. Alteration of cyclin D1 in Chinese patients with breast carcinoma and its correlation with Ki-67, pRb, and p53.
Guo LL; Gao P; Wu YG; Jian WC; Hao CY; Li H; Lin XY
Arch Med Res; 2007 Nov; 38(8):846-52. PubMed ID: 17923265
[TBL] [Abstract][Full Text] [Related]
48. Deregulated expression of p27(Kip1) in human breast cancers.
Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB
Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577
[TBL] [Abstract][Full Text] [Related]
49. Psoriasin (S100A7) expression and invasive breast cancer.
Al-Haddad S; Zhang Z; Leygue E; Snell L; Huang A; Niu Y; Hiller-Hitchcock T; Hole K; Murphy LC; Watson PH
Am J Pathol; 1999 Dec; 155(6):2057-66. PubMed ID: 10595935
[TBL] [Abstract][Full Text] [Related]
50. RanBPM interacts with psoriasin in vitro and their expression correlates with specific clinical features in vivo in breast cancer.
Emberley ED; Gietz RD; Campbell JD; HayGlass KT; Murphy LC; Watson PH
BMC Cancer; 2002 Nov; 2():28. PubMed ID: 12421467
[TBL] [Abstract][Full Text] [Related]
51. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.
Moubayed N; Weichenthal M; Harder J; Wandel E; Sticherling M; Gläser R
J Cancer Res Clin Oncol; 2007 Apr; 133(4):253-61. PubMed ID: 17136347
[TBL] [Abstract][Full Text] [Related]
52. Differential distribution of ErbB-2 and pS2 proteins in ductal carcinoma in situ of the breast.
Inaji H; Koyama H; Motomura K; Noguchi S
Breast Cancer Res Treat; 1996; 37(1):89-92. PubMed ID: 8750531
[TBL] [Abstract][Full Text] [Related]
53. Loss of ICAM-1 signaling induces psoriasin (S100A7) and MUC1 in mammary epithelial cells.
Petersson S; Shubbar E; Yhr M; Kovacs A; Enerbäck C
Breast Cancer Res Treat; 2011 Jan; 125(1):13-25. PubMed ID: 20217214
[TBL] [Abstract][Full Text] [Related]
54. Epithelial hyperplasia of usual type expresses both S100-alpha and S100-beta in a heterogeneous pattern but ductal carcinoma in situ can express only S100-alpha in a monotonous pattern.
Ichihara S; Koshikawa T; Nakamura S; Yatabe Y; Kato K
Histopathology; 1997 Jun; 30(6):533-41. PubMed ID: 9205857
[TBL] [Abstract][Full Text] [Related]
55. WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.
Ugolini F; Charafe-Jauffret E; Bardou VJ; Geneix J; Adélaïde J; Labat-Moleur F; Penault-Llorca F; Longy M; Jacquemier J; Birnbaum D; Pébusque MJ
Oncogene; 2001 Sep; 20(41):5810-7. PubMed ID: 11593386
[TBL] [Abstract][Full Text] [Related]
56. Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes.
Jiang WG; Watkins G; Douglas-Jones A; Mansel RE
Int J Oncol; 2004 Jul; 25(1):81-5. PubMed ID: 15201992
[TBL] [Abstract][Full Text] [Related]
57. Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues.
Ahn SH; Sawada H; Ro JY; Nicolson GL
Clin Exp Metastasis; 1997 Mar; 15(2):151-6. PubMed ID: 9062391
[TBL] [Abstract][Full Text] [Related]
58. Elevated expression of eIF4E in confined early breast cancer lesions: possible role of hypoxia.
DeFatta RJ; Turbat-Herrera EA; Li BD; Anderson W; De Benedetti A
Int J Cancer; 1999 Feb; 80(4):516-22. PubMed ID: 9935150
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of survivin immunoexpression in the differentiation of high- and low-grade breast ductal carcinoma in situ.
Chade MC; Piato S; Galvão MAL; Aldrighi JM; Negrini R; Mateus EF; Medeiros EM
Einstein (Sao Paulo); 2018; 16(1):eAO4065. PubMed ID: 29694611
[TBL] [Abstract][Full Text] [Related]
60. Psoriasin (S100A7) expression is altered during skin tumorigenesis.
Alowami S; Qing G; Emberley E; Snell L; Watson PH
BMC Dermatol; 2003 Feb; 3():1. PubMed ID: 12600274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
